Company overview
ENPICOM provides a unified bioinformatics platform that integrates large-scale biologics data, AI models, and ML frameworks for lab and data scientists in antibody discovery and development. The platform eliminates data silos, enables instant access to sequencing datasets, and supports seamless integration with LIMS, ELNs, and cloud storage via a comprehensive API. They also offer immune repertoire sequencing (Rep-Seq) analysis services using the ImmunoGenomiX (IGX) platform, leveraging expertise in immunology and bioinformatics.
Enpicom is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, Software & Digital Lab partner serving United States & Americas. Core focus areas include enpicom, bioinformatics platform, immune repertoire analysis, antibody discovery, ai biologics, rep-seq data.
Industry categories: Life Science Reagents, Software & Digital Lab. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://enpicom.com
- Categories
- Life Science Reagents, Software & Digital Lab
- Markets served
- United States & Americas
- Keywords
- enpicom, bioinformatics platform, immune repertoire analysis, antibody discovery, ai biologics, rep-seq data
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What core capabilities does ENPICOM offer for biologics R&D?
- ENPICOM's platform provides unified bioinformatics for processing large-scale sequencing data, AI model deployment, data integration, and immune repertoire analysis to accelerate antibody discovery.
- What integrations does the ENPICOM platform support?
- It integrates with LIMS, ELNs, cloud storage like S3, Google Cloud, and Azure, plus federated data warehouses via a comprehensive API for seamless data synchronization.
- Does ENPICOM offer services beyond their platform?
- Yes, they provide immune repertoire sequencing (Rep-Seq) analysis services through the ImmunoGenomiX (IGX) platform, including full on-demand sequencing and analysis with partners.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
